HOMA‐IR at study end was most consistently reduced by NT‐0796 monotherapy, or NT‐0796 in combination with semaglutide, but these did not reach statistical significance (Figure S3F ).
← all excerpts
The NLRP3 inhibitor NT-0796 enhances and sustains GLP-1R agonist-mediated weight loss in a murine diet-induced obesity model.
1
—
—